6505--Radiopharmaceuticals | VA San Diego | Base Year
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
This amendment to solicitation 36C26226Q0072 shall answer questions.
All other terms and conditions remain unchanged.
The solicitation shall close on 11/10/2025 at 0900 PT local time.
Question: For the I-131 DX and TX caps, do you want the dollar amount to be listed per mCi, or as the total dollar amount for the activity requested (i.e. 4mCi and 150mCi capsules?)
Answer: The hospital will order different doses so please provide pricing per mCi.
Question: The price of GA68 Dotatate (NETSPOT) is dictated by the manufacturer and updated on a quarterly basis. How we handle any price adjustments set by the manufacturer (i.e. do we have to ask for a contract amendment if Novartis changes the price during the contract period?)
Answer: This is a firm fixed price contract.